3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EON Resources said an error in its depletion, depreciation and amortization expense for 2025 overstated that expense, so its 2025 Form 10-K filed September 28, 2026 should no longer be relied upon. The company expects to file an amended 10-K showing the loss attributable to shareholders falling from $10.1 million to about $7.5 million, but the change is non-cash and the figures remain preliminary pending audit completion.
Depletion, depreciation and amortization expense for fiscal 2025 was overstated by $3,540,000, and the net loss decreased by $2,632,000.
Loss attributable to EON Resources shareholders for 2025 is expected to be reduced from $10.1 million to approximately $7.5 million.
Management determined on October 8, 2026 that the 2025 Form 10-K should no longer be relied upon.
The restatement has no impact on cash flows or cash, cash equivalents and marketable investments; figures remain subject to audit and review, which the company discussed with CBIZ CPAs P.C.
Starry Sea Acquisition Corp postponed its extraordinary general meeting from October 9 to October 19, 2026 to allow more time to engage with shareholders. As of the October 7, 2026 redemption deadline, 4,281,993 public shares had been submitted for redemption, leaving 1,468,007 public shares outstanding, and the company is seeking to reverse redemption requests on about 350,174 shares.
Meeting moved from 10:00 a.m. ET on October 9, 2026 to 9:00 a.m. ET on October 19, 2026.
4,281,993 public shares submitted for redemption as of October 7, 2026; 1,468,007 public shares outstanding.
Company is seeking reversal of redemption requests on about 350,174 public shares; if achieved, at least 1,818,181 would remain outstanding.
At 1,818,181 remaining shares, the company estimates a monthly extension contribution of about $59,999.97 at $0.033 per share, below the $60,000 cap.
Gran Tierra stockholders approved the sale of the company's Colombian and Ecuadorian businesses to Maurel & Prom at a special meeting on October 9, 2026. The company expects about $315 million in net cash proceeds and targets closing on or about December 31, 2026, pending regulatory approvals in Colombia and Ecuador. Stockholders did not approve the non-binding advisory vote on compensation for named executive officers tied to the sale, with more votes against than for.
Sale approved: 19,351,115 shares for, 32,492 against, 7,328 abstaining, out of 19,390,935 shares represented at the meeting
Advisory vote on sale-related executive compensation: 9,557,007 for, 9,658,068 against, 175,860 abstaining
Expected net cash proceeds of about $315 million: about $250 million at closing and about $65 million 364 days later
Closing targeted on or about December 31, 2026, subject to regulatory approvals in Colombia and Ecuador; any share repurchase depends on completion of the sale
Streamex Corp. received a Nasdaq notice on October 7, 2026, saying its stock has not met the $1.00 minimum bid price for 30 consecutive business days. The company has until April 5, 2027 to regain compliance, and its shares continue to trade on the Nasdaq Capital Market under STEX for now. The notice does not change the listing today, but it signals that the stock has traded below the required level and could lead to delisting if the company fails to comply.
Nasdaq notice dated October 7, 2026, covers closing bid prices from August 25, 2026 through October 6, 2026
Compliance period runs 180 calendar days, until April 5, 2027, to regain the $1.00 minimum bid price
A possible reverse stock split would need to be completed no later than ten business days before April 5, 2027
Company may be eligible for an additional 180-day period, and the filing says there is no assurance it will regain compliance
On October 9, 2026, Flyte Aviation agreed to sell 2,050 shares of Series C-4 Convertible Preferred Stock to existing investors for $2.05 million, with closing expected on or about October 13, 2026. The same day, the company cut the conversion price of its Series C, Series D and Series J preferred stock from $2.30 to $1.00 per share (Series J was reduced to $1.00), which could increase the number of common shares issuable to those holders and may dilute existing shareholders.
2,050 Series C-4 preferred shares at a $1,000 stated value, for $2.05 million in gross proceeds; Dawson James Securities acted as placement agent
Series C-4 shares convertible at $1.00 per share into up to 2,050,000 shares of common stock
Conversion price cut from $2.30 to $1.00 for Series C-1, C-2, C-3, C-4 and Series D preferred stock, with the floor price waived
Series J conversion price reduced to $1.00; the company effected a 1-for-10 reverse stock split on October 5, 2026
Volato Group, Inc. (the filing names this company, not SOAR AI, Inc.) signed an equity line of credit with DFU, LLC that lets it sell up to $1,000,000,000 of Class A common stock over 36 months, at its own discretion. The deal also requires issuing 3,646,974 common shares and 13,058 Series B preferred shares convertible into 56,528,082 common shares, which would dilute existing shareholders.
Up to $1,000,000,000 of Class A common stock may be sold to DFU, LLC over a 36-month Investment Period, at the company's discretion.
Each Put Notice may cover up to $6,000,000 in shares, with a floor price of $0.21 per share.
Commitment Shares: 3,646,974 common shares plus 13,058 Series B preferred shares convertible into 56,528,082 common shares, subject to NYSE American approval.
Without stockholder approval, sales cannot exceed 19.99% of outstanding shares as of October 8, 2026.
Vivakor, Inc. announced a non-binding Letter of Intent to acquire 100% of Direct Midstream, LLC, a Midland, Texas water midstream company, at a gross purchase price of $40 million. The deal remains subject to due diligence, audited financial statements, a fairness opinion, and a definitive agreement, and the company says there is no assurance it will be completed. The filing also disclosed conversion of $350,000 of a junior secured note into 128,965 common shares.
Gross purchase price of $40 million, based on four times Direct Midstream's targeted 2027 free cash flow of $10 million
At closing, Vivakor would invest $10 million in Direct Midstream, reducing the consideration payable dollar-for-dollar
Remaining consideration would be about $29 million of Series B Preferred Stock and $1 million of common stock, before debt or working capital adjustments
Between October 5 and October 6, 2026, J.J. Astor converted $350,000 of its Second Note into 128,965 common shares
Sidus Space disclosed that two board members resigned effective October 6, 2026: Tiffany Norwood, who also chaired the Audit Committee, and Kelle Wendling. Both cited governance and oversight concerns, and the company disagrees with their stated reasons. The departures remove the audit committee chair and raise questions about board oversight for shareholders.
Tiffany Norwood resigned from the Board, as Audit Committee Chairwoman, and from the Corporate Governance/Nominating Committee, effective October 6, 2026 at 7:15 p.m. ET, citing disagreements over governance and oversight, including handlin
Kelle Wendling resigned from the Board and from the Audit, Compensation and Corporate Governance/Nominating Committees, effective October 6, 2026 at 1:00 p.m. ET, citing concerns about management and governance.
The company said it respectfully disagrees with the substance and characterizations in both resignation letters; both letters are filed as Exhibits 17.1 and 17.2.
NextBoat Inc. said its Chief Financial Officer, Chad Corbin, has decided to resign, with notice given to CEO Ross Tannenbaum on October 5, 2026. Corbin will remain CFO during a transition period until a successor is identified, and the filing says the departure did not result from any disagreement with the company on operations, policies or practices. For shareholders, a CFO change is a significant leadership event, though the filing gives no successor name or timing.
Chad Corbin notified CEO Ross Tannenbaum of his resignation as CFO on October 5, 2026.
Corbin will continue as CFO during a transition period until a successor is identified.
The filing states the resignation was not due to any disagreement with the company on operations, policies or practices.
The 8-K was filed October 9, 2026; no successor CFO is named in the filing.
Profusa dismissed CBIZ CPAs as its independent auditor on October 5, 2026, and engaged WithumSmith+Brown for fiscal 2026. CBIZ's prior audit report for 2025 included a going-concern paragraph and the company disclosed unremediated material weaknesses in internal control, which matters to shareholders because it signals financial reporting and viability concerns.
CBIZ CPAs dismissed on October 5, 2026; its 2025 audit report had no adverse opinion or disclaimer but included a going-concern explanatory paragraph.
Material weaknesses in internal control, including segregation of duties and complex debt and equity accounting, had not been remediated as of June 30, 2026.
WithumSmith+Brown engaged on October 6, 2026, for the fiscal year ending December 31, 2026, following Audit Committee and Board approval on September 30, 2026.
No disagreements with CBIZ were reported; CBIZ's response letter is filed as Exhibit 16.1.
Quantum Corporation terminated Chief Financial Officer William H. White effective October 9, 2026, and appointed Chief Accounting Officer Hiral A. Patel as Principal Financial Officer the same day. The company said it is early in its closing process for the quarter ended September 30, 2026, but expects to meet or exceed its previously issued guidance, a view subject to completion of closing procedures and audit review. The filing does not state a reason for the termination.
William H. White terminated as CFO and principal financial officer effective October 9, 2026; the company says no disruption to operations is expected
Hiral A. Patel, Chief Accounting Officer since September 1, 2026, appointed Principal Financial Officer effective October 9, 2026
Company expects to meet or exceed guidance for the quarter ended September 30, 2026, but results remain subject to closing and auditor review
Company expects to timely file its Form 10-Q for the quarter ended September 30, 2026
On October 9, 2026, Vaxcyte closed the sale of $575 million of 1.50% convertible senior notes due 2032, including an over-allotment option exercised in full, and a separate equity offering of 7,412,500 shares at $64.00 each plus pre-funded warrants. The filing reports net proceeds of approximately $558.7 million from the notes and $544.3 million from the equity offering, and notes that conversion of the notes would be settled in cash, shares, or a mix at Vaxcyte's election, which could dilute shareholders if shares are issued.
Convertible notes: $575 million principal, 1.50% interest, maturing October 15, 2032, with an initial conversion price of approximately $89.60 per share
Equity offering: 7,412,500 shares at $64.00 per share plus 400,000 pre-funded warrants, with a 1,171,875-share option exercised in full on October 7, 2026
Approximate net proceeds: $558.7 million from the notes and $544.3 million from the equity offering, after underwriting discounts and expenses
Both offerings were underwritten by Jefferies LLC and Leerink Partners LLC and closed on October 9, 2026
Standard Motor Products said Chief Financial Officer Nathan Iles will resign to take a CFO position at another public company, effective after he remains in his role until October 30, 2026. The Board appointed director James J. Burke as Interim CFO effective October 30, 2026, until a permanent successor is named, and the company has started an executive search. The company said the resignation was voluntary and not due to any disagreement over operations, financial reporting, policies, or practices.
Nathan R. Iles remains CFO through October 30, 2026
James J. Burke becomes Interim CFO effective October 30, 2026 and stays on the Board
Company has begun an executive search for a permanent CFO
Company is scheduled to report third quarter and nine-month 2026 earnings before market open on October 30, 2026
MSG Rangers Corp., formerly MSGS Spinco, Inc., disclosed that its Form 10 registration statement became effective on October 9, 2026, and that Joseph M. Cohen was appointed to its board and to the Audit and Compensation Committees. The distribution of its shares to MSG Sports stockholders is expected to take effect at 11:59 p.m. New York City time on October 26, 2026, when the company will own the New York Rangers business and begin trading on the NYSE as MSGR.
Registration statement effective October 9, 2026 at 4:00 p.m. New York City time; distribution expected October 26, 2026 at 11:59 p.m.
Record date is October 20, 2026; holders receive one Spinco Class A share for every two MSG Sports Class A shares held
Joseph M. Cohen appointed director effective October 9, 2026, and named to the Audit and Compensation Committees
Dolan Family Group expected to hold about 63.4% of total voting power after the distribution
Shareholders approved an amendment extending the company's deadline to complete a business combination from October 9, 2026 to April 9, 2027, in monthly steps up to six times or an earlier date set by the board. Holders of 18,322,071 public shares redeemed for about $198.6 million, about $10.84 per share, leaving 4,677,929 public shares outstanding.
Shareholders approved extending the business combination deadline from October 9, 2026 to April 9, 2027, in monthly steps up to six times.
Holders of 18,322,071 Class A public shares redeemed for about $198.6 million, about $10.84 per share.
Investors holding 4,481,851 Class A shares agreed not to redeem and to vote for the extension; the sponsor will transfer 256,061 Class A shares to them per extension month at the closing of an initial business combination.
Shareholders also ratified WithumSmith+Brown, PC as independent auditor for the year ending December 31, 2026, with 23,647,778 votes for.
Universal Safety Products, Inc. (the filing names this company, not DeFi Capital Markets or DCM as the request stated) entered into an amended and restated securities purchase agreement on October 9, 2026 with SJC Lending LLC for up to $2.5 million in convertible note financing. Conversion shares above 19.99% of common stock require new stockholder approval, and the notes convert at a discount to recent trading prices, which would dilute existing shareholders.
Up to $2,650,000 in convertible notes for up to $2.5 million; $1,000,000 funded June 12, 2026 and $500,000 funded July 29, 2026, with a third $1,000,000 tranche due after a resale registration statement is declared effective
Conversion price is the greater of a $1.00 floor or 80% of the lowest five-day VWAP, capped at $10.00 per share; conversions above 19.99% of shares outstanding need stockholder approval
Notes accrue 8% interest (20% after an event of default) and mature one year after issuance; the company may not enter a variable rate transaction for one year and SJC holds a one-year right of first refusal on future equity offerings
Evernorth Holdings, formerly the Armada Acquisition Corp II SPAC, closed its business combination with Ripple's XRP contribution on October 9, 2026, making Pubco the successor registrant. Holders of 18,463,753 public shares redeemed for about $193.6 million, and the filing's pro forma figures show a $264.1 million digital assets impairment for the six months ended June 30, 2026, which weighs on the combined company's results.
Closing took place October 9, 2026; 4,536,247 public shares remained outstanding and about $47.6 million was released from the trust account.
Public share holders redeemed 18,463,753 shares for about $193.6 million, or about $10.49 per share.
Ripple contributed 126,791,458 XRP tokens; the Closing XRP Price of $1.43069 was below the $2.36609 signing price, and amended agreements reduced the shares issuable to investors.
Pro forma digital assets impairment was $264.1 million and pro forma net loss attributable to the parent was $268.7 million for the six months ended June 30, 2026; lock-ups last six months after closing.
DENTSPLY SIRONA obtained lender consent and amended its revolving credit facility and three note purchase agreements, effective around September 30, 2026. The changes raise the maximum permitted leverage ratios for the quarters ending September 30 and December 31, 2026, and add tighter limits on new liens, subsidiary debt and restricted payments. The company says the revised terms are intended to keep it in compliance with its debt covenants in all material respects.
Maximum permitted Total Leverage Ratio and Senior Leverage Ratio increased for fiscal quarters ending September 30, 2026 and December 31, 2026.
Until the compliance certificate for fiscal 2026 is delivered, new liens and new subsidiary debt are generally prohibited, and restricted payments are limited with certain carveouts.
Credit facility adds a new pricing level for the applicable margin and facility fee; note interest increases if leverage meets specified thresholds.
Phoenix Education Partners said its Chief Financial Officer and Treasurer, Blair Westblom, will separate from the company effective October 10, 2026, and named Michael Cochran, its Senior Vice President of Corporate Development, as interim CFO. The filing says her departure was not the result of any disagreement on financial reporting, internal controls, operations, policies or practices, and it sets out $1,137,204 in cash severance and other separation benefits.
Blair Westblom, CFO and Treasurer, separates from the company effective October 10, 2026.
Michael Cochran, 39, appointed interim CFO effective October 10, 2026; he has served as SVP of Corporate Development since April 2026.
Separation Agreement includes aggregate cash severance of $1,137,204, a fiscal 2026 cash bonus, and accelerated equity vesting.
No compensation decisions have been made for Cochran's interim role; the Separation Agreement is expected to be filed with the 10-K for the fiscal year ending August 31, 2026.
Century Financial Services Corporation shareholders voted on October 9, 2026, to approve the merger agreement with Bank7 Corp. Bank7 also received regulatory approval or non-objection from the Federal Reserve and the New Mexico Financial Institutions Division, and the merger is expected to close on or about November 1, 2026, subject to other closing conditions.
Century shareholders approved the Merger Agreement at a special meeting on October 9, 2026.
Merger Agreement is dated September 16, 2026; Century will merge into Bank7 Corp.
Federal Reserve and New Mexico Financial Institutions Division approval or non-objection received.
Closing expected on or about November 1, 2026, subject to other conditions.
Lunai Bioworks asked Nasdaq on October 9, 2026 to immediately suspend trading in its stock, citing trading records from its pending Delaware litigation that it says raise serious questions about whether trading has occurred in a fair and orderly market. Nasdaq has not decided, and the request itself does not halt trading, so shareholders face uncertainty about whether trading will continue.
Request submitted to Nasdaq on October 9, 2026, asking for an immediate trading suspension while Nasdaq, FINRA and other authorities review trading records
Records cited include substantial short selling, locate deficiencies and concentrated failures to deliver, based on court-ordered discovery in Lunai Bioworks, Inc. v. Seven Points Capital LLC et al.
As of the filing, Nasdaq had not responded, and the company cannot predict if or when it will act; allegations have not been adjudicated
Art's-Way Manufacturing reported third-quarter fiscal 2026 sales of $5,615,000, down from $6,432,000, and a net loss of $140,000, compared with net income of $254,000 a year earlier. For the first nine months, sales rose to $20,110,000 from $17,910,000, but net income fell to $230,000 from $1,680,000, and nine-month EPS dropped to $0.04 from $0.33. The company also took a $956,000 term loan from Bank Midwest to buy a new fiberoptic laser and crane system.
Q3 (three months ended August 31, 2026): sales $5,615,000 vs. $6,432,000; net loss $140,000 vs. net income $254,000; EPS $(0.03) vs. $0.05
Nine months ended August 31, 2026: sales $20,110,000 vs. $17,910,000; net income $230,000 vs. $1,680,000; EPS $0.04 vs. $0.33
Management cited rising material and operating costs pressuring margins, and a prior-year Employee Retention Credit that did not repeat in fiscal 2026
Laser Loan of $956,000 dated October 5, 2026; 6.65% fixed for the first 60 payments, then 1-month SOFR plus 3.1%; initial monthly payment $8,456
IT Tech Packaging, Inc. is not in compliance with NYSE American continued listing standards because it has not filed its 2025 Form 10-K or its Form 10-Qs for the quarters ended March 31 and June 30, 2026 on time. NYSE Regulation accepted the company's extension request and set a plan period through April 15, 2027, so the stock remains listed for now. If the company misses the deadline or does not make progress under the plan, the exchange will start delisting proceedings, which would put shareholders' listing at risk.
Delayed filings: Form 10-K for the year ended December 31, 2025, and Forms 10-Q for the quarters ended March 31, 2026 and June 30, 2026.
Extension request submitted October 1, 2026; NYSE Regulation accepted it in a letter received October 7, 2026.
New cure deadline is April 15, 2027; failure to complete the filings or make progress could lead to delisting proceedings.
Stock continues trading on NYSE American with a late filer (.LF) indicator; the company expects to file on time but states there is no assurance.
TruGolf Holdings completed its acquisition of Polymath Research Inc. on October 8, 2026, through an amalgamation that made Polymath a wholly owned subsidiary. Polymath shareholders received 257,494 Class A common shares and 136,956 Series C convertible preferred shares, and the company must reserve $2,500,000 of working capital for Polymath's operations and related costs. Series C preferred conversion is blocked until stockholder and Nasdaq approvals are obtained, and the filing says the conversion price was amended to $11.82 per share.
Acquisition of Polymath Research Inc. consummated October 8, 2026; Polymath became a wholly owned subsidiary.
Polymath shareholders received 257,494 Class A common shares and 136,956 Series C preferred shares.
Series C preferred conversion price amended to $11.82 per share; stated value $1,000 per share.
Company must reserve $2,500,000 of working capital and use efforts to complete $500,000 of golf-related financings within six months.
Stride entered into a cooperation agreement on October 8, 2026 with activist investor Fivespan Partners and related parties. The deal adds Dylan Haggart as a director effective October 30, 2026 and Steven Guttentag as a board observer, and forms a Capital Allocation Committee to review the company's capital structure. Shareholders will be asked for input, and the company says it will announce a target capital structure and cash flow allocation framework after the committee's initial review, expected within three months.
Dylan Haggart joins the board effective October 30, 2026, serving until the 2027 Annual Meeting; Steven Guttentag is a board observer effective immediately and joins the board after the 2026 Annual Meeting on December 10, 2026.
Allison Lawrence resigned from the board and the Compensation Committee on October 8, 2026, and will serve as a non-voting observer until re-appointed.
The Capital Allocation Committee has three voting members: Brian Shepherd and Dylan Haggart as co-chairs, and Aida Alvarez; CEO Robert E. Knowling, Jr. is a non-voting member.
The investor group withdrew its director nominations, stockholder proposal and books-and-records demand for the 2026 Annual Meeting.
On October 5, 2026, authID entered into an agreement to sell $1,350,000 of senior secured convertible debentures and warrants to four accredited investors, and the offering closed on October 6, 2026. The debentures carry no interest, mature on February 28, 2027 or earlier upon a change of control, and are secured by substantially all company assets, while the holders of the April 2026 debentures agreed to extend their own maturity to the same date. For shareholders, the conversion and warrant terms could add significant share dilution and the new secured debt ranks alongside the April 2026 debentures.
Gross proceeds of $1,350,000 from the offering, before placement agent fees and expenses, closed October 6, 2026.
Debentures convert at $0.386 per share into an aggregate of 3,497,409 shares and mature February 28, 2027.
Warrants cover 1,800,000 shares at $0.50 per share and cannot be exercised until stockholder approval is obtained.
April 2026 debenture maturity moved from October 29, 2026 to February 28, 2027, with the warrant exercise price cut from $0.57 to $0.50.
Quince Therapeutics renamed itself IRulya Therapeutics effective October 9, 2026, following its merger with privately held Orphai Therapeutics. Brigette Roberts, M.D., was appointed Chief Executive Officer effective October 8, 2026, succeeding Dirk Thye, M.D., who resigned as CEO, Chief Medical Officer and director, and John Militello, CPA, and Keith Fandrick, Ph.D., were named Chief Financial Officer and Chief Operating Officer. The company's common stock is expected to begin trading on Nasdaq under the symbol IRLA on October 12, 2026.
Brigette Roberts, M.D., named CEO effective October 8, 2026, with an annual base salary of $600,000 and a target bonus of 50% of base salary
John Militello, CPA, named CFO with a $440,000 base salary; a restricted stock unit award for 80,000 shares is subject to Board approval
Keith Fandrick, Ph.D., named COO with a $450,000 base salary; Brendan Hannah resigned as COO, Chief Business Officer and Chief Compliance Officer
Cash balance of $116 million as of June 30, 2026, expected to fund operations through the end of 2028; common stock expected to be about 10,841,470 shares after Series C conversion
Avient Corporation's board elected Mike Frank, former CEO of UPL Corporation, as President and Chief Executive Officer effective October 7, 2026, succeeding Dr. Ashish K. Khandpur. The company also reaffirmed its third quarter and full year 2026 guidance from August 6, 2026, and said its third quarter closing procedures are ongoing.
Mike Frank elected President and CEO and a board member effective October 7, 2026; Khandpur stepped down and will serve in an advisory role through December 31, 2026
Richard H. Fearon, Lead Independent Director, elected Non-Executive Chairman of the Board
Third quarter and full year 2026 guidance reaffirmed; third quarter 2026 earnings scheduled for November 4, 2026
Frank's sign-on package includes a $1,600,000 cash payment and RSUs valued at about $5,000,000; his base salary is $1,222,000 per year
On October 8, 2026, GigCapital8 Corp. entered into a merger agreement with Quantisimo Corp., WISeQey and SEALSQ, under which GigCapital8 and Quantisimo would become wholly owned subsidiaries of a newly formed holding company, Quantisimo Holding Corp., expected to list on Nasdaq under the symbol QSMO. The deal is subject to GigCapital8 shareholder approval, a minimum cash condition of $15 million, and an expected completion in the first quarter of 2027, so shareholders will be asked to vote on the transaction.
Merger Agreement dated October 8, 2026; joint press release issued October 9, 2026.
Quantisimo's owners would receive 66,610,000 PubCo shares, an implied pro forma equity value of approximately $666.1 million at $10.00 per share.
Closing is conditioned on available cash of at least $15 million; the outside date is March 31, 2027.
GigCapital8's sponsor agreed to vote in favor of the transaction and not to redeem its shares; WISeQey, SEALSQ and the sponsor agreed to six-month lock-ups.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.